Natus Medical Incorporated (NASDAQ:BABY) Files An 8-K Results of Operations and Financial Condition
Item 2.02.
|
Results of Operations and Financial Condition
|
issuing a press release regarding 2017 annual and first quarter
financial guidance including fourth quarter and full year 2016
revenue estimates. A copy of the press release is furnished as
Exhibit 99.1 to this Current Report on Form 8-K.
shall not be deemed “filed” for purposes of Section 18 of the
Securities Exchange Act of 1934 (the “Exchange Act”) or otherwise
subject to the liabilities of that Section, nor shall it be deemed
incorporated by reference in any filing under the Securities Act of
1933 or the Exchange Act, except as shall be expressly set forth by
specific reference in such a filing.
|
Item 9.01.
|
Financial Statements and Exhibits
|
Exhibit No.
|
|
Description
|
|
99.1
|
|
Press release dated January 9, 2017 describing the
Company’s 2017 annual and first quarter financial guidance and other financial information. |
About Natus Medical Incorporated (NASDAQ:BABY)
Natus Medical Incorporated is a provider of newborn care and neurology healthcare products and services used for the screening, diagnosis, detection, treatment, monitoring and tracking of common medical ailments in newborn care, hearing impairment, neurological dysfunction, epilepsy, sleep disorders, neuromuscular diseases and balance and mobility disorders. The Company’s segment is neurology and newborn care product families. Its product offerings include computerized neurodiagnostic systems for audiology, neurology, polysomnography, and neonatology, as well as newborn care products, such as hearing screening systems, phototherapy devices for the treatment of newborn jaundice, head-cooling products for the treatment of brain injury in newborns, incubators to control the newborn’s environment, and software systems for managing and tracking disorders and diseases for public health laboratories. It is organized into two strategic business units: Neurology and Newborn Care. Natus Medical Incorporated (NASDAQ:BABY) Recent Trading Information
Natus Medical Incorporated (NASDAQ:BABY) closed its last trading session up +2.05 at 37.80 with 873,774 shares trading hands.
